Parkinson’s

  • New research offers possible explanation for why Parkinson’s is more common in men

    Scientists have found a potential new target for treating Parkinson's disease - finding that a protein in brain cells may drive Parkinson's onset. The finding offers a possible explanation for why Parkinson's is much more common in men. In recent years, La Jolla Institute for Immunology (LJI) scientists have found increasing evidence that autoimmunity plays [...]

  • Interview: The world-first neurosurgery / tech collaboration that could revolutionise neuro-rehab

    A Newcastle hospital is one of just four in the world to implant an innovative brain device in Parkinson’s patients that has been shown to help relieve movement disorder symptoms by up to 80 per cent. The brain stimulation device - Brainsense - consisting of implanted wires in the brain that attach to a monitor [...]

  • Scale of challenge faced by Parkinson’s caregivers revealed in new report

    One in two family caregivers of people with Parkinson’s are juggling their responsibilities with an estimated 37 hours a week of employment, a new report suggests.  The scale of the challenge faced on a daily basis by many family caregivers of people with Parkinson’s has been set out in a new report. It highlights the [...]

  • Research roundup: Detecting Alzheimer’s and the gut-brain connection, how sleep impacts Parkinson’s

    NR Times explores the latest research developments impacting on neuro-rehab. Researchers develop a new approach to detecting Alzheimer’s disease New research has identified a link between disrupted brain oxygenation dynamics and neuronal function in Alzheimer’s disease, suggesting that neurodegeneration may stem from insufficient nourishment of the brain via the vascular system. For the new study, [...]

  • Could ‘systems biology’ revolutionise the diagnosis and treatment of Parkinson’s?

    A new approach combining AI and genetics could be used to identify the risk factors of Parkinson's, and drugs that could potentially be repurposed to treat the condition, scientists say.  Researchers have created an advanced AI-meets-genetics model described as "systems biology" which uses AI to integrate and analyse a range of info, including genetic, proteomic, [...]

  • Parkinson’s update: Why momentum is building in the hunt for new treatments and earlier diagnosis

    Parkinson’s disease is the fastest growing neurological disorder worldwide, with a current dearth of disease-modifying therapies due to late diagnosis and the lack of a reliable diagnostic test. Research undertaken over the last decade, however, has contributed to a better understanding of the condition’s causes and mechanisms, helping to advance new treatments and avenues of [...]

  • Calls to serve on the Federal Advisory Council on Parkinson’s Research

    The National Institutes of Health (NIH) is calling for individuals to serve on the Federal Advisory Council on Parkinson’s Research, Care, and Services that will provide advice on Parkinson’s-related issues, including recommendations for priority actions to be included in the national plan. The implementation US's National Plan to End Parkinson’s Act, which aims to eliminate [...]

  • Hearing impairment may be a sign of increased risk of Parkinson’s disease

    There may be a link between hearing impairment and an increased risk of developing Parkinson’s disease, new research suggests. The study is one of the first to examine whether sensory impairments, such as hearing loss, might increase the risk for Parkinson’s or serve as an early warning sign. Parkinson's UK reports that an estimated 153,000 [...]

  • Ketamine can help address dyskinesia in Parkinson’s, reveals study

    Ketamine may help address levodopa-induced dyskinesia in Parkinson's disease, according to a new study. Levodopa is administered to Parkinson's patients to help counter the loss of dopamine that contributes to the condition. However, after years of this treatment, many patients experience involuntary and uncontrollable movements known as levodopa-induced dyskinesia. In a new study, researchers have [...]

  • Parkinson’s campaigner honoured with Presidential Medal of Freedom

    Actor, author, advocate and founder of The Michael J. Fox Foundation for Parkinson's Research (MJFF), Michael J. Fox, has been recognised with the Presidential Medal of Freedom, the U.S's highest civilian honour, at a White House ceremony. President Biden presented Fox with the medal, which honours individuals who have made exemplary contributions to the prosperity, [...]